Nasdaq (NDAQ) Competitors

CME Group (NASDAQ:CME) and Nasdaq (NASDAQ:NDAQ) are both large-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk, community ranking and dividends.

Is CME or NDAQ more profitable?

CME Group has a net margin of 57.52% compared to Nasdaq's net margin of 15.10%. Nasdaq's return on equity of 14.82% beat CME Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CME Group	57.52%	13.62%	2.81%
Nasdaq	15.10%	14.82%	5.37%

Is CME or NDAQ a better dividend stock?

CME Group pays an annual dividend of $5.00 per share and has a dividend yield of 1.8%. Nasdaq pays an annual dividend of $1.08 per share and has a dividend yield of 1.4%. CME Group pays out 50.3% of its earnings in the form of a dividend. Nasdaq pays out 49.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Nasdaq has raised its dividend for 13 consecutive years.

Does the media prefer CME or NDAQ?

In the previous week, CME Group had 4 more articles in the media than Nasdaq. MarketBeat recorded 54 mentions for CME Group and 50 mentions for Nasdaq. Nasdaq's average media sentiment score of 1.06 beat CME Group's score of 0.85 indicating that Nasdaq is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CME Group	34 Very Positive mention(s)	2 Positive mention(s)	9 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Nasdaq	30 Very Positive mention(s)	4 Positive mention(s)	10 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community prefer CME or NDAQ?

Nasdaq received 207 more outperform votes than CME Group when rated by MarketBeat users. Likewise, 69.43% of users gave Nasdaq an outperform vote while only 58.59% of users gave CME Group an outperform vote.

Company	Underperform	Outperform
CME Group	Outperform Votes 672 58.59%	Underperform Votes 475 41.41%
Nasdaq	Outperform Votes 879 69.43%	Underperform Votes 387 30.57%

Which has more volatility and risk, CME or NDAQ?

CME Group has a beta of 0.43, meaning that its share price is 57% less volatile than the S&P 500. Comparatively, Nasdaq has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500.

Do analysts rate CME or NDAQ?

CME Group presently has a consensus price target of $256.80, indicating a potential downside of 7.05%. Nasdaq has a consensus price target of $85.18, indicating a potential upside of 10.39%. Given Nasdaq's stronger consensus rating and higher probable upside, analysts plainly believe Nasdaq is more favorable than CME Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CME Group	3 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.25
Nasdaq	1 Sell rating(s)	4 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.67

Do institutionals and insiders hold more shares of CME or NDAQ?

87.8% of CME Group shares are held by institutional investors. Comparatively, 72.5% of Nasdaq shares are held by institutional investors. 0.3% of CME Group shares are held by company insiders. Comparatively, 0.7% of Nasdaq shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Which has preferable earnings and valuation, CME or NDAQ?

CME Group has higher earnings, but lower revenue than Nasdaq. CME Group is trading at a lower price-to-earnings ratio than Nasdaq, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CME Group	$6.28B	15.84	$3.53B	$9.94	27.79
Nasdaq	$7.82B	5.67	$1.12B	$2.20	35.07

Summary

Nasdaq beats CME Group on 14 of the 22 factors compared between the two stocks.